1620330-72-4Cc1ccc(S(=O)(=O)NO)o1LIXKIXWSKOENAB-UHFFFAOYSA-NCimlanod is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).
1620330-72-4DTXSID801288087CHEMBL4297915Wird geladen…
Wird geladen…
Wird geladen…